Recordati SpA (RCDTF)
58.79
0.00 (0.00%)
USD |
OTCM |
Oct 05, 16:00
Recordati Gross Profit Margin (Quarterly) : 71.41% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 71.41% |
| March 31, 2026 | 71.60% |
| December 31, 2025 | 71.37% |
| September 30, 2025 | 68.38% |
| June 30, 2025 | 65.83% |
| March 31, 2025 | 67.47% |
| December 31, 2024 | 69.07% |
| September 30, 2024 | 69.09% |
| June 30, 2024 | 66.84% |
| March 31, 2024 | 68.37% |
| December 31, 2023 | 67.84% |
| September 30, 2023 | 65.12% |
| June 30, 2023 | 69.91% |
| March 31, 2023 | 70.32% |
| December 31, 2022 | 69.75% |
| September 30, 2022 | 68.06% |
| June 30, 2022 | 67.79% |
| March 31, 2022 | 72.46% |
| December 31, 2021 | 72.94% |
| September 30, 2021 | 72.22% |
| June 30, 2021 | 73.61% |
| March 31, 2021 | 72.96% |
| December 31, 2020 | 72.23% |
| September 30, 2020 | 71.08% |
| June 30, 2020 | 73.94% |
| Date | Value |
|---|---|
| March 31, 2020 | 70.76% |
| December 31, 2019 | 71.73% |
| September 30, 2019 | 70.39% |
| June 30, 2019 | 70.35% |
| March 31, 2019 | 69.59% |
| December 31, 2018 | 70.63% |
| September 30, 2018 | 70.69% |
| June 30, 2018 | 71.56% |
| March 31, 2018 | 70.18% |
| December 31, 2017 | 70.66% |
| September 30, 2017 | 70.97% |
| June 30, 2017 | 70.56% |
| March 31, 2017 | 69.06% |
| December 31, 2016 | 67.88% |
| September 30, 2016 | 68.37% |
| June 30, 2016 | 69.62% |
| March 31, 2016 | 69.00% |
| December 31, 2015 | 68.26% |
| September 30, 2015 | 67.66% |
| June 30, 2015 | 68.10% |
| March 31, 2015 | 67.98% |
| December 31, 2014 | 66.46% |
| September 30, 2014 | 68.55% |
| June 30, 2014 | 66.01% |
| March 31, 2014 | 66.59% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| AstraZeneca PLC | 76.09% |
| ANI Pharmaceuticals, Inc. | 54.97% |
| Corcept Therapeutics, Inc. | 98.41% |
| Veru, Inc. | -- |
| Avadel Pharmaceuticals Plc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 25.20% |
| Return on Assets | 9.43% |
| Return on Invested Capital | 11.32% |
| Profit Margin (Quarterly) | 16.72% |
| Operating Margin (Quarterly) | 29.21% |
| Return on Net Operating Assets | 10.87% |